Vantia Ltd: Clinical Trials

5 trials sponsored by Vantia Ltd, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed. 5 Phase 2, 1 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 25Completed 5
Phase 11Completed 1
Phase 31Completed 1

Follow Vantia Ltd: new trials by email

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
Fedovapagon 2 mg, Placebo - Nocturia
Phase 2 / Phase 3CompletedVantia Ltd4322016-03-012018-10-31
Dose Range Finding Study of Fedovapagon in Men With Nocturia
fedovapagon 1 mg, fedovapagon 2 mg, fedovapagon 4 mg - Nocturia
Phase 2CompletedVantia Ltd3582012-08-012014-06-20
Efficacy Study of VA106483 in Males With Nocturia.
VA106483 - Nocturia
Phase 2CompletedVantia Ltd1522009-12-012014-06-20
VA111913 Dysmenorrhoea Efficacy and Safety Proof of Concept
VA111913 TS and placebo - Primary Dysmenorrhea
Phase 2CompletedVantia Ltd1462009-08-012014-05-22
Efficacy and Safety of VA106483 in Elderly Males
VA106483, Sugar pill - Nocturia
Phase 1 / Phase 2CompletedVantia Ltd272008-08-012018-10-31

Conditions studied

Nocturia (4)  ·  Dysmenorrhea (1)  ·  Hyponatremia (1)  ·  Pain (1)  ·  Prostatic Hyperplasia (1)

Interventions

Sugars (2)

Countries

United States (4)  ·  United Kingdom (2)

Top investigators

Aris Nikas (1)  ·  Bruce Rankin (1)  ·  Chris Ng (1)  ·  David Beccia (1)  ·  David Bell (1)  ·  Earl Martin (1)  ·  Elizabeth Houser (1)  ·  Evan Goldfischer (1)  ·  H. David Mitcheson (1)  ·  Hilary McElwaine-Johnn, BSc, ASM, MBBS, MRCP, MFPM (1)  ·  Howard Hezmall (1)  ·  Joseph Parkhurst (1)  ·  Kenneth Blaze (1)  ·  Leah Schmidt (1)  ·  Louise Taber (1)